Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
BUSINESS / Companies
Jul 17, 2020
Japan in talks with Johnson & Johnson to secure COVID-19 vaccine
The company has already agreed to prioritize an allocation to the United States as part of a funding agreement, according to the firm's chief financial officer.
Japan Times
WORLD / FOCUS
Jul 17, 2020
Coronavirus cold war flares up with claims of Russian vaccine hack
The international race for protection from the virus escalated to a new level with allegations that vaccine development has become a target of Russian cyberattacks.
Japan Times
JAPAN
Jul 17, 2020
Japan and Germany agree to cooperate over COVID-19 vaccine development
Abe told Merkel that his country will contribute to the development and distribution of vaccines through the WHO's ACT-Accelerator.
Japan Times
BUSINESS / Companies
Jul 14, 2020
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.
Japan Times
JAPAN / Science & Health
Jul 10, 2020
Avigan's effectiveness inconclusive in Japan COVID-19 trial
Promoted heavily by Prime Minister Shinzo Abe, the flu drug did not yield any statistically significant results after administered to 89 patients across Japan.
Japan Times
COMMENTARY / World
Jul 8, 2020
The fight over a coronavirus vaccine will get ugly
Once COVID-19 shots become available, there will be arguments about who gets them, and an even bigger battle with anti-vaxxers who refuse them.
Japan Times
WORLD / Science & Health
Jul 7, 2020
Moderna spars with U.S. scientists over COVID-19 vaccine trials
As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc., one of the leading developers, it has been learned.
Japan Times
BUSINESS / Companies
Jul 6, 2020
Takeda considers sale of OTC drug unit to focus on profitable products
Takeda Pharmaceutical Co. is considering selling its over-the-counter medicine unit for around ¥400 billion ($3.7 billion) to focus on developing cancer treatments and other advanced medical-use drugs that can generate higher profitability, a source said Monday.
Japan Times
BUSINESS
Jul 3, 2020
How Moderna execs are cashing in during the race to develop COVID-19 vaccine
Biotech firm Moderna Inc. could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.
Japan Times
ASIA PACIFIC / Science & Health
Jul 2, 2020
How China's CanSino Biologics jumped to the front of the coronavirus vaccine race
The firm has boosted its scientific prowess by tying up with the Canadian government's largest research organization, maintaining links despite geopolitical rows.
Japan Times
JAPAN / Science & Health
Jul 1, 2020
Eisai to start clinical trial of experimental drug for COVID-19
Japanese pharmaceutical firm Eisai Co. is set to start clinical trials in the United States of its experimental drug eritoran in the battle against coronavirus, with results potentially available by the year-end, the company said Wednesday.
Japan Times
BUSINESS
Jul 1, 2020
Fujifilm ties up with Indian firm on potential COVID-19 drug Avigan
The drug has yet to be approved by the Japanese government for coronavirus treatment, with clinical testing delayed due to insufficient enrollment.
Japan Times
JAPAN / Science & Health
Jun 24, 2020
Wanted: More COVID-19 patients in Japan ... for clinical trials
Japan has become a victim of its own success as slowing new infections have led to a shortage of patients to enroll in trials for treatments and vaccines.
JAPAN / Science & Health
Jun 23, 2020
Osaka's Rohto to begin stem cell clinical trial for COVID-19 in August
Rohto Pharmaceutical Co. said Tuesday it will begin a clinical trial in August using stem cells for a potential treatment for patients severely ill with COVID-19.
Japan Times
BUSINESS / Companies
Jun 23, 2020
Gilead targets remdesivir supply for 2 million COVID-19 patients by year-end
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, which is currently administered only intravenously.
Japan Times
BUSINESS / Companies
Jun 22, 2020
Japan drugmaker to tie up with universities to develop new test method for coronavirus
Japanese pharmaceutical company Shionogi & Co. said Monday that it will collaborate with universities in the country to put into practical use a new testing method for the novel coronavirus.
Japan Times
JAPAN / Science & Health
Jun 12, 2020
Daiichi Sankyo sees clinical test for genetic COVID-19 vaccine in March
The vaccine contains messenger RNA that causes cells to produce proteins that could trigger the body to produce effective antibodies.
JAPAN / Science & Health
Jun 11, 2020
Drugmaker eyes stem cell clinical test for coronavirus treatment
Japanese drugmaker Rohto Pharmaceutical Co. said Thursday it plans to launch a clinical trial using stem cells to develop a treatment for severe cases of COVID-19, the respiratory illness caused by the novel coronavirus.
Japan Times
BUSINESS / Markets
Jun 8, 2020
Chugai stock surges 60% to rival Sony's value on hopes for virus treatment
Chugai Pharmaceutical is now Japan's biggest drug company by market value after overtaking Daiichi Sankyo and Takeda Pharmaceutical.
Japan Times
BUSINESS
Jun 7, 2020
Fujifilm's COVID-19 drug research will drag on into July, source says
The recent fall in the number of confirmed infections has made it difficult to reach the enrollment target of 96 patients.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'